Join LBG’s Kristi Sarno at the Biosimilar Market Access and Commercialization Strategies Summit in September. Kristi will be presenting a workshop, “Uncover Market Access of Biosimilars in the U.S. Market”, that will help stakeholders identify key issues related to the U.S. biosimilar landscape and review effective strategies for market access and will focus on the Commercialization of Biosimilars including Navigating the Crossroads Between Business Development, Product Development, and Strategic Portfolio Management, and Pricing and Naming Considerations for Biosimilar Pipelines.
The Biosimilar Market Access and Commercialization Strategies Summit will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests. Its talented faculty will address everything from navigating evolving regulations, analyzing optimal pricing models, accelerating market access strategies, and executing strategic decisions to mitigate risk and build for commercial success. In addition, designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.